Stromedix Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $562M

Stromedix General Information

Description

Developer of therapies for fibrosis organ failure. The company remodels tissues.

Contact Information

Website
www.stromedix.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • One Canal Park
  • Suite 1120
  • Cambridge, MA 02141
  • United States
Primary Industry
Biotechnology
Acquirer
Biogen
Corporate Office
  • One Canal Park
  • Suite 1120
  • Cambridge, MA 02141
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stromedix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 08-Mar-2012 $562M Completed Clinical Trials - Phase 2
4. Debt - General 24-Jan-2011 Completed Clinical Trials - Phase 1
3. Early Stage VC (Series B) 23-Apr-2008 Completed Clinical Trials - Phase 1
2. Early Stage VC 26-Mar-2008 $600K $5M Completed Product Development
1. Early Stage VC (Series A) 08-Mar-2007 $4.4M $4.4M Completed Product Development
To view Stromedix’s complete valuation and funding history, request access »

Stromedix Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A
To view Stromedix’s complete cap table history, request access »

Stromedix Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Atlas Venture Venture Capital Minority
Bessemer Venture Partners Venture Capital Minority
Frazier Healthcare Partners PE/Buyout Minority
New Leaf Venture Venture Capital Minority
Red Abbey Venture Partners Venture Capital Minority
To view Stromedix’s complete investors history, request access »

Ready to get started?

Request a free trial

Stromedix FAQs

  • When was Stromedix founded?

    Stromedix was founded in 2006.

  • Where is Stromedix headquartered?

    Stromedix is headquartered in Cambridge, MA.

  • What industry is Stromedix in?

    Stromedix’s primary industry is Biotechnology.

  • Is Stromedix a private or public company?

    Stromedix is a Private company.

  • What is the current valuation of Stromedix?

    The current valuation of Stromedix is .

  • What is Stromedix’s current revenue?

    The current revenue for Stromedix is .

  • How much funding has Stromedix raised over time?

    Stromedix has raised $32M.

  • Who are Stromedix’s investors?

    Atlas Venture, Bessemer Venture Partners, Frazier Healthcare Partners, New Leaf Venture, and Red Abbey Venture Partners have invested in Stromedix.

  • When was Stromedix acquired?

    Stromedix was acquired on 08-Mar-2012.

  • Who acquired Stromedix?

    Stromedix was acquired by Biogen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »